Stemcell Holdings Stock Net Income
| STMM Stock | USD 0.06 0.00 0.00% |
Fundamental analysis of Stemcell Holdings allows traders to better anticipate movements in Stemcell Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
Stemcell |
Stemcell Holdings Company Net Income Analysis
Stemcell Holdings' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Stemcell Holdings Net Income | 2.41 M |
Most of Stemcell Holdings' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stemcell Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Stemcell Holdings reported net income of 2.41 M. This is 99.29% lower than that of the Healthcare sector and 96.56% lower than that of the Biotechnology industry. The net income for all United States stocks is 99.58% higher than that of the company.
Stemcell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stemcell Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Stemcell Holdings could also be used in its relative valuation, which is a method of valuing Stemcell Holdings by comparing valuation metrics of similar companies.Stemcell Holdings is currently under evaluation in net income category among its peers.
Stemcell Fundamentals
| Return On Equity | 0.68 | |||
| Return On Asset | 0.34 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | (3.47 M) | |||
| Shares Outstanding | 27.38 M | |||
| Shares Owned By Insiders | 85.22 % | |||
| Price To Book | 0.27 X | |||
| Price To Sales | 0.16 X | |||
| Revenue | 6.18 M | |||
| Gross Profit | 4.99 M | |||
| EBITDA | 3.73 M | |||
| Net Income | 2.41 M | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | 2.52 M | |||
| Earnings Per Share | 0.11 X | |||
| Number Of Employees | 28 | |||
| Market Capitalization | 1.64 M | |||
| Total Asset | 6.42 M | |||
| Net Asset | 6.42 M |
About Stemcell Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stemcell Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stemcell Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stemcell Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Stemcell Pink Sheet
Stemcell Holdings financial ratios help investors to determine whether Stemcell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemcell with respect to the benefits of owning Stemcell Holdings security.